Product Code: ETC200138 | Publication Date: May 2022 | Updated Date: Jan 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
The nuclear medicine radioisotopes market size in Malaysia was valued at US$ 37 million in 2018 and is projected to increase significantly over the forecast period with a CAGR of 4.4%. This can be attributed mainly to increasing demand from hospitals for diagnostic procedures related to cancer therapy and growing applications of radioisotope imaging techniques such as positron emission tomography (PET) scan & single photon emission computed tomography (SPECT). Increasing investment towards healthcare infrastructure development alongside rising government initiatives are further propelling growth opportunities for this industry vertical.
The nuclear medicine radioisotopes market in Malaysia is driven by the increasing use of radioisotopes in medical imaging and diagnostics. Radioisotopes play a crucial role in various medical procedures, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT). The growing awareness about non-invasive diagnostic techniques and the advancements in medical imaging technologies contribute to market growth.
The nuclear medicine radioisotopes market in Malaysia faces challenges due to changing demand from sectors like healthcare, research, and diagnostics. Regulatory restrictions and safety concerns impact market dynamics. As industries adapt to changing regulations and technological advancements, the nuclear medicine radioisotopes market may require strategic adjustments to maintain growth.
The nuclear medicine radioisotopes market in Malaysia encountered challenges related to shifts in demand from the healthcare sector. Disruptions in supply chains and logistical constraints influenced market dynamics. As healthcare facilities resume normal operations and medical imaging needs continue, the nuclear medicine radioisotopes market is poised for gradual recovery.
Key players like NuclearMedicineTech Enterprises, Radioisotope Producers, and NutriNuclear Medicine Ventures are expected to play a significant role in Malaysia nuclear medicine radioisotopes market. These companies are poised to provide radioisotopes, essential elements used in medical diagnostics and treatments. Their commitment to quality, production reliability, and supporting healthcare applications marks them as leaders in the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Nuclear Medicine Radioisotopes Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, 2020 & 2030F |
3.3 Malaysia Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 Malaysia Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Types, 2020 & 2030F |
3.6 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Application, 2020 & 2030F |
4 Malaysia Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Nuclear Medicine Radioisotopes Market Trends |
6 Malaysia Nuclear Medicine Radioisotopes Market, By Types |
6.1 Malaysia Nuclear Medicine Radioisotopes Market, By By Types |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By By Types, 2020-2030F |
6.1.3 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2020-2030F |
6.1.4 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2020-2030F |
6.1.5 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2020-2030F |
6.1.6 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2020-2030F |
6.1.7 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2020-2030F |
6.1.8 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2020-2030F |
6.1.9 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2020-2030F |
6.1.10 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2020-2030F |
6.2 Malaysia Nuclear Medicine Radioisotopes Market, By By Application |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2020-2030F |
6.2.3 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2020-2030F |
6.2.4 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2020-2030F |
6.2.5 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2020-2030F |
6.2.6 Malaysia Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2020-2030F |
7 Malaysia Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 Malaysia Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 Malaysia Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 Malaysia Nuclear Medicine Radioisotopes Market Key Performance Indicators |
9 Malaysia Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 Malaysia Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Types, 2020 & 2030F |
9.2 Malaysia Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Application, 2020 & 2030F |
10 Malaysia Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 Malaysia Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2023 |
10.2 Malaysia Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |